Seamless phase II/III designs

In recent years, there has been a drive to save development costs and shorten time-to-market of new therapies. Research into novel trial designs to facilitate this goal has led to, amongst other approaches, the development of methodology for seamless phase II/III designs. Such designs allow treatment or dose selection at an interim analysis and comparative evaluation of efficacy with control, in the same study. Methods have gained much attention because of their potential advantages compared to conventional drug development programmes with separate trials for individual phases. In this article, we review the various approaches to seamless phase II/III designs based upon the group-sequential approach, the combination test approach and the adaptive Dunnett method. The objective of this article is to describe the approaches in a unified framework and highlight their similarities and differences to allow choice of an appropriate methodology by a trialist considering conducting such a trial.

[1]  P. Bauer,et al.  Evaluation of experiments with adaptive interim analyses. , 1994, Biometrics.

[2]  Hayne W. Reese,et al.  Multiple comparison methods. , 1970 .

[3]  T. Friede,et al.  A comparison of methods for adaptive sample size adjustment , 2001, Statistics in medicine.

[4]  C. Dunnett.  A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .

[5]  Tim Friede,et al.  A Comparison of Methods for Adaptive Treatment Selection , 2008, Biometrical journal. Biometrische Zeitschrift.

[6]  Nigel Stallard,et al.  A New Clinical Trial Design Combining Phases 2 and 3: Sequential Designs with Treatment Selection and a Change of Endpoint , 2005 .

[7]  Nigel Stallard,et al.  Sequential designs for phase III clinical trials incorporating treatment selection , 2003, Statistics in medicine.

[8]  Frank Bretz,et al.  Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts , 2006, Biometrical journal. Biometrische Zeitschrift.

[9]  W. Brannath,et al.  Selection and bias—Two hostile brothers , 2009, Statistics in medicine.

[10]  Jeff Maca,et al.  Adaptive Seamless Phase II/III Designs—Background, Operational Aspects, and Examples , 2006 .

[11]  H. Schäfer,et al.  A general statistical principle for changing a design any time during the course of a trial , 2004, Statistics in medicine.

[12]  K. Gabriel,et al.  On closed testing procedures with special reference to ordered analysis of variance , 1976 .

[13]  Nigel Stallard,et al.  Point estimates and confidence regions for sequential trials involving selection , 2005 .

[14]  B. Turnbull,et al.  Repeated confidence intervals for group sequential clinical trials. , 1984, Controlled clinical trials.

[15]  Christopher Jennison,et al.  Numerical Computations for Group Sequential Tests , 1999 .

[16]  P. Armitage,et al.  Repeated Significance Tests on Accumulating Data , 1969 .

[17]  Richard Simon,et al.  Two-stage selection and testing designs for comparative clinical trials , 1988 .

[18]  H Merabet,et al.  The design and analysis of sequential clinical trials , 2013 .

[19]  Patrick J. Kelly,et al.  A Practical Comparison of Group-Sequential and Adaptive Designs , 2005, Journal of biopharmaceutical statistics.

[20]  John Whitehead,et al.  Estimation following selection of the largest of two normal means. Journal of Statistical Planning and Inference 138, 1629-1638. , 2008 .

[21]  L B Sheiner,et al.  Learning versus confirming in clinical drug development , 1997, Clinical pharmacology and therapeutics.

[22]  C. Burman,et al.  Are Flexible Designs Sound? , 2006, Biometrics.

[23]  P F Thall,et al.  A two-stage design for choosing among several experimental treatments and a control in clinical trials. , 1989, Biometrics.

[24]  K. K. Lan,et al.  Discrete sequential boundaries for clinical trials , 1983 .

[25]  W. Brannath,et al.  Recursive Combination Tests , 2002 .

[26]  Martin Posch,et al.  Testing and estimation in flexible group sequential designs with adaptive treatment selection , 2005, Statistics in medicine.

[27]  P. Bauer,et al.  Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections by H. Schäfer and H.‐H. Müller, Statistics in Medicine 2001; 20: 3741–3751 , 2004, Statistics in medicine.

[28]  M. Krams,et al.  Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group , 2006, Journal of biopharmaceutical statistics.

[29]  L Shen,et al.  An improved method of evaluating drug effect in a multiple dose clinical trial , 2001, Statistics in medicine.

[30]  N Stallard,et al.  Comparison of the spending function method and the Christmas tree correction for group sequential trials. , 1996, Journal of biopharmaceutical statistics.

[31]  M Kieser,et al.  Combining different phases in the development of medical treatments within a single trial. , 1999, Statistics in medicine.

[32]  Frank Bretz,et al.  Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations , 2006, Biometrical journal. Biometrische Zeitschrift.

[33]  Frank Bretz,et al.  Adaptive Dunnett tests for treatment selection , 2008, Statistics in medicine.

[34]  Christopher Jennison,et al.  Group Sequential Analysis Incorporating Covariate Information , 1997 .

[35]  Nigel Stallard,et al.  A confirmatory seamless phase II/III clinical trial design incorporating short‐term endpoint information , 2010, Statistics in medicine.

[36]  W. Lehmacher,et al.  Adaptive Sample Size Calculations in Group Sequential Trials , 1999, Biometrics.

[37]  Bruce W Turnbull,et al.  Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Opportunities and Limitations , 2006, Biometrical journal. Biometrische Zeitschrift.

[38]  Tim Friede,et al.  A group‐sequential design for clinical trials with treatment selection , 2008, Statistics in medicine.

[39]  David L. DeMets,et al.  Design and analysis of group sequential tests based on the type I error spending rate function , 1987 .

[40]  Terry M. Therneau,et al.  Optimal two-stage screening designs for survival comparisons , 1990 .

[41]  丹後 俊郎,et al.  Adaptive Group Sequential Designs for Clinical Trials , 2003 .

[42]  Christopher Jennison,et al.  Interim analyses: the repeated confidence interval approach , 1989 .

[43]  B. Turnbull,et al.  Group Sequential Methods with Applications to Clinical Trials , 1999 .

[44]  M. Proschan,et al.  Designed extension of studies based on conditional power. , 1995 .